Bergamonte® has been studied across the interconnected factors that shape cardiometabolic health, including blood sugar, lipid balance, body composition, liver function, vascular health, and healthy inflammatory signaling.
One of Bergamonte®’s strongest differentiators is the breadth of its cardiometabolic research. Studies have evaluated multiple systems within the same populations, allowing formulators to work from data that reflects the interconnected nature of metabolic health rather than piecing together unrelated single-endpoint studies.
Broad Clinical Dataset
Research spans glucose, lipids, BMI, liver markers, and vascular measurements.
Multiple Study Durations
Human studies include 30-, 90-, and 120-day protocols.
Advanced Biomarkers
Research includes HOMA-IR, lipoprotein subclasses, hs-CRP, and TNF-α.
Systems-Based Science
Mechanistic research connects metabolic signaling, lipid handling, and cellular energy regulation.
Cardiometabolic health is shaped by a cluster of interconnected factors rather than one isolated measurement. Glucose regulation, lipid metabolism, abdominal weight, liver function, vascular health, and inflammatory signaling can all influence one another. Bergamonte® has been studied across this multi-marker landscape, making it particularly relevant for product concepts built around comprehensive metabolic wellness.
Key Clinical Benefits
Bergamonte® research has simultaneously evaluated cardiovascular and metabolic measurements including cholesterol, LDL-C, HDL-C, triglycerides, fasting glucose, BMI, endothelial function, and inflammatory biomarkers. This breadth allows formulators to address cardiometabolic wellness as an interconnected system and helps distinguish the ingredient from products backed by only one or two metabolic endpoints.
Efficient glucose metabolism requires coordinated glucose uptake, insulin signaling, energy production, and liver function. Clinical studies of Bergamot Polyphenolic Fraction have measured fasting glucose and HOMA-IR, while mechanistic research has explored AMPK and glucose-transporter pathways. Together, the data support a formulation story centered on the body’s ability to use and manage glucose efficiently.
Bergamonte® research extends from conventional cholesterol and triglyceride measurements to VLDL, IDL, and LDL and HDL particle subclasses. These advanced measurements provide product developers with a more complete lipid story within the larger context of metabolic wellness.
Human studies in participants with metabolic syndrome have evaluated several interconnected markers, including fasting glucose, lipid balance, insulin sensitivity, Atherogenic Index of Plasma and liver-related metabolic measures. Together, the research provides a broader view of how bergamot-based formulations have been studied across the metabolic profile rather than through a single endpoint alone.
Why it matters: One protocol showed significant changes across several core metabolic markers..
A separate 90-day randomized, double-blind study evaluated pectin-enriched BPE-C in participants with metabolic syndrome and elevated AIP. Mean AIP declined from approximately 0.45 to 0.27 at 650 mg/day and from 0.46 to 0.19 at 1,300 mg/day, with the stronger response at the higher intake.
Why it matters: The study extends the metabolic story beyond fasting glucose alone.
The 120-day BPF study also measured liver-related and inflammatory biomarkers in participants with metabolic syndrome and NAFLD. Significant changes were reported in ALT, AST, γ-GT, hs-CRP, TNF-α and hepatorenal index, broadening the clinical picture beyond circulating glucose and lipids.
Why it matters: The findings add liver and inflammatory context to the metabolic profile.
Study results reflect the specific formulations, intake levels, populations and durations evaluated. The 120-day BPF protocol also included oleuropein and ascorbic acid; results should not be assumed to apply interchangeably across all Bergamonte® ingredient options.
Metabolic wellness reflects the way several systems work together. Glucose regulation influences energy utilization, lipids affect cardiovascular health, the liver helps coordinate nutrient metabolism, and body composition and inflammatory signaling can influence the entire metabolic environment. Looking at one marker in isolation can therefore miss much of the bigger picture.
This interconnected biology is one of the strongest reasons Bergamonte® fits metabolic-health formulations. Its research spans many of these systems within the same clinical program, creating a cohesive scientific platform for brands seeking broader cardiometabolic positioning.
Bergamonte® is uniquely suited to multi-target metabolic formulas because one ingredient platform connects several major cardiometabolic systems within a single research story.
Metabolic syndrome involves interconnected changes in glucose regulation, lipid metabolism, body weight, vascular function and liver health. The most relevant Bergamonte® options therefore come from the parts of the portfolio built around broad, multi-marker metabolic research rather than a single isolated endpoint.
let’s get started
Discuss your formulation goals, intended positioning, research needs, and product-development opportunities with the HP Ingredients team.
Schedule Now
Evaluate Bergamonte® for your next product concept with a sample for formulation, compatibility, and product-development testing.
Request Now
Ready to explore how Bergamonte® can support your product pipeline? Contact HP Ingredients for samples, technical documentation, clinical research, formulation guidance, and next-step support.
Contact Us